Douglas Ringler
10Patents
4h-index
17Co-inventors
53Inventor score
Filing activity: Feb 10, 1995 → Aug 1, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7147851B1 | Humanized immunoglobulin reactive with α4β7 integrin | Chemistry; Metallurgy | 47 | Expired |
| US6551593B1 | Treatment of Inflammatory bowel disease by inhibiting binding and/or signalling through &agr; 4 &bgr; 7 and its ligands and madcam | Emerging Cross-Sectional Technologies | 39 | Expired |
| US7402410B2 | Humanized immunoglobulin reactive with α4β7 integrin | Chemistry; Metallurgy | 7 | Active |
| US7265201B1 | Human chemotactic cytokine | Chemistry; Metallurgy | 4 | Expired |
| US7803904B2 | Mucosal vascular addressing and uses thereof | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7947272B2 | Compositions and methods of tolerizing a primate to an antigen | Chemistry; Metallurgy | 0 | Active |
| US7423129B2 | Antibodies to human eotaxin | Chemistry; Metallurgy | 0 | Active |
| US7858326B2 | Method of diagnosis of inflammatory disease using eotaxin antibodies | Chemistry; Metallurgy | 0 | Active |
| US7541443B2 | Anti-CD4 antibodies | Chemistry; Metallurgy | 0 | Expired |
| US7285620B2 | Human chemotactic cytokine | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.